These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19963109)

  • 1. The tumor suppressor gene FBXW7 is disrupted by a constitutional t(3;4)(q21;q31) in a patient with renal cell cancer.
    Kuiper RP; Vreede L; Venkatachalam R; Ricketts C; Kamping E; Verwiel E; Govaerts L; Debiec-Rychter M; Lerut E; van Erp F; Hoogerbrugge N; van Kempen L; Schoenmakers EF; Bonne A; Maher ER; Geurts van Kessel A
    Cancer Genet Cytogenet; 2009 Dec; 195(2):105-11. PubMed ID: 19963109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma.
    Kanayama H; Lui WO; Takahashi M; Naroda T; Kedra D; Wong FK; Kuroki Y; Nakahori Y; Larsson C; Kagawa S; Teh BT
    J Med Genet; 2001 Mar; 38(3):165-70. PubMed ID: 11238683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor gene.
    Wake NC; Ricketts CJ; Morris MR; Prigmore E; Gribble SM; Skytte AB; Brown M; Clarke N; Banks RE; Hodgson S; Turnell AS; Maher ER; Woodward ER
    Hum Mutat; 2013 Dec; 34(12):1650-61. PubMed ID: 24000165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
    Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
    Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of a novel MFS transporter gene, DIRC2, by a familial renal cell carcinoma-associated t(2;3)(q35;q21).
    Bodmer D; Eleveld M; Kater-Baats E; Janssen I; Janssen B; Weterman M; Schoenmakers E; Nickerson M; Linehan M; Zbar B; van Kessel AG
    Hum Mol Genet; 2002 Mar; 11(6):641-9. PubMed ID: 11912179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
    Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
    Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic and molecular analysis of early stage renal cell carcinomas in a family with a translocation (2;3)(q35;q21).
    Bodmer D; Eleveld M; Ligtenberg M; Weterman M; van der Meijden A; Koolen M; Hulsbergen-van der Kaa C; Smits A; Smeets D; Geurts van Kessel A
    Cancer Genet Cytogenet; 2002 Apr; 134(1):6-12. PubMed ID: 11996788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of renal cell carcinoma-associated constitutional chromosome abnormalities by genome sequencing.
    Smith PS; Whitworth J; West H; Cook J; Gardiner C; Lim DHK; Morrison PJ; Hislop RG; Murray E; ; Tischkowitz M; Warren AY; Woodward ER; Maher ER
    Genes Chromosomes Cancer; 2020 Jun; 59(6):333-347. PubMed ID: 31943436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBXW7 overexpression suppresses renal cancer cell proliferation and induces apoptosis.
    Fu Y; Lin Y; Yang Z; Yang G; Li G; Liu Y; Tan X; Huang Y; Wu X; Wang Y; Xiong H; Zhang M; Fang L; Ge Y; Zeng J; Cai Y; Bai J; Wu S
    Med Oncol; 2015 Aug; 32(8):215. PubMed ID: 26163148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.
    Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A
    Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetic analysis of clustered sporadic and familial renal cell carcinoma-associated 3q13 approximately q22 breakpoints.
    Bodmer D; Janssen I; Jonkers Y; van den Berg E; Dijkhuizen T; Debiec-Rychter M; Schoenmakers E; van Kessel AG
    Cancer Genet Cytogenet; 2002 Jul; 136(2):95-100. PubMed ID: 12237231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fbxw7/hCdc4 tumor suppressor in human cancer.
    Tan Y; Sangfelt O; Spruck C
    Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability.
    Kemp Z; Rowan A; Chambers W; Wortham N; Halford S; Sieber O; Mortensen N; von Herbay A; Gunther T; Ilyas M; Tomlinson I
    Cancer Res; 2005 Dec; 65(24):11361-6. PubMed ID: 16357143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FBXW7 and DNA copy number instability.
    Byrd KN; Huey B; Roydasgupta R; Fridlyand J; Snijders AM; Albertson DG
    Breast Cancer Res Treat; 2008 May; 109(1):47-54. PubMed ID: 17588203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning of a new familial t(3;8) translocation associated with conventional renal cell carcinoma reveals a 5 kb microdeletion and no gene involved in the rearrangement.
    Rodríguez-Perales S; Meléndez B; Gribble SM; Valle L; Carter NP; Santamaría I; Conde L; Urioste M; Benítez J; Cigudosa JC
    Hum Mol Genet; 2004 May; 13(9):983-90. PubMed ID: 15016767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias.
    Song JH; Schnittke N; Zaat A; Walsh CS; Miller CW
    Leuk Res; 2008 Nov; 32(11):1751-5. PubMed ID: 18485478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of CDC4/FBXW7 in gastric carcinoma.
    Milne AN; Leguit R; Corver WE; Morsink FH; Polak M; de Leng WW; Carvalho R; Offerhaus GJ
    Cell Oncol; 2010; 32(5-6):347-59. PubMed ID: 20448329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of germline t(3;6) and t(3;12) associated with conventional renal cell carcinomas indicates their rate-limiting role and supports the three-hit model of carcinogenesis.
    Yusenko MV; Nagy A; Kovacs G
    Cancer Genet Cytogenet; 2010 Aug; 201(1):15-23. PubMed ID: 20633763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.